Antithymocyte globulin-induced acute renal failure

American Journal of Kidney Diseases

Volumn 34, Issue 6, 1999, Pages 1155-

  Levine, J M ^a   Lien, Y H H ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; THYMOCYTE ANTIBODY;

ACUTE KIDNEY FAILURE; ADULT; APLASTIC ANEMIA; CASE REPORT; DRUG INDUCED DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LETTER; MALE; NEPHROTOXICITY;

EID: 0032739954     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70028-4     Document Type: Letter

References (6)

1. R Champlin W Ho RP Gale Antithymocyte globulin treatment in patients with aplastic anemia N Engl J Med 308 1983 113 118
2. E Gluckman H Esperou-Bourdeau A Baruchel M Boogaerts D Donadio G Leverger M Leporrier J Reiffers M Janvier M Michallet P Stryckmans the Cooperative Group on the Treatment of Aplastic Anemia Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia Blood 79 1992 2540 2546
3. TG Cantu EW Hoehn-Saric KM Burgess L Racusen P Scheel Acute renal failure associated with immunoglobulin therapy Am J Kidney Dis 25 1995 228 234
4. E Tan M Hajinazarian W Bay J Neff JR Mendell Acute renal failure resulting from intravenous immunoglobulin therapy Arch Neurol 50 1993 137 139
5. R Rault B Piraino JR Johnston A Oral Pulmonary and renal toxicity of intravenous immunoglobulin Clin Nephrol 36 1991 83 86
6. BD Kahan Cyclosporine nephrotoxicity: Pathogenesis prophylaxis, therapy and prognosis Am J Kidney Dis 8 1986 323 331